← FDA DRUG APPROVALS

FDA ANDA · ANDA086413

TRIAMCINOLONE ACETONIDE

Sponsor: PADAGIS US

APPLICATION
ANDA086413
TYPE
ANDA
ORIGINAL APPROVAL
1981-04-09
LATEST ACTION
2002-01-25
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Prescription

Products

TRIAMCINOLONE ACETONIDEPrescription
TRIAMCINOLONE ACETONIDE 0.025% · CREAM · TOPICAL
TRIAMCINOLONE ACETONIDEPrescription
TRIAMCINOLONE ACETONIDE 0.1% · CREAM · TOPICAL
TRIAMCINOLONE ACETONIDEPrescription
TRIAMCINOLONE ACETONIDE 0.5% · CREAM · TOPICAL

Approval history

2002-01-25Manufacturing (CMC) · Supplement 14AP
1996-12-10Labeling · Supplement 13AP
1993-01-25Labeling · Supplement 12AP
1992-06-08Labeling · Supplement 11AP
1986-06-09Manufacturing (CMC) · Supplement 10AP
1986-04-28Manufacturing (CMC) · Supplement 6AP
1984-07-11Manufacturing (CMC) · Supplement 7AP
1982-06-16Manufacturing (CMC) · Supplement 5AP
1981-04-09OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →